Le Lézard
Classified in: Health
Subject: SVY

Global Intragastric Balloons Market 2018-2022


NEW YORK, Sept. 24, 2018 /PRNewswire/ -- About Intragastric Balloons

Intragastric balloon, also known as stomach balloon, is an inflatable medical device, which is temporarily placed into the stomach to reduce weight. It limits the amount of food the stomach can hold and causes a feeling of fullness and satiety, which leads to less intake of food and resultant weight loss.

Read the full report: https://www.reportlinker.com/p03112414

Technavio's analysts forecast the Global Intragastric Balloons Market to grow at a CAGR of 25.18% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the intragastric balloons market. To calculate the market size, the report considers the revenue generated by sales of intragastric balloons across the globe.

The market is divided into the following segments based on geography:
? Americas
? APAC
? EMEA

Technavio's report, intragastric balloons market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
? Allurion Technologies
? Apollo Endosurgery
? Helioscopie
? Obalon Therapeutics
? ReShape Lifesciences
? Spatz FGIA

Market driver
? Cost-effectiveness and safety of intragastric balloons
? For a full, detailed list, view our report

Market challenge
? Complications associated with intragastric balloon treatment
? For a full, detailed list, view our report

Market trend
? Increasing preference for weight loss procedures
? For a full, detailed list, view our report

Key questions answered in this report
? What will the market size be in 2022 and what will the growth rate be?
? What are the key market trends?
? What is driving this market?
? What are the challenges to market growth?
? Who are the key vendors in this market space?
? What are the market opportunities and threats faced by the key vendors?
? What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Read the full report: https://www.reportlinker.com/p03112414

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: